Earnings · China A-shares
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A (600329) earnings
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A published its Q3 report on 2026-10-30: net profit -57.40% year on year, +11.46% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +5.48% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -57.40%
- Excl. one-offs YoY
- +11.46%
- Net profit QoQ
- +23.15%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +5.56% | — |
| 3 days | +5.48% | — |
| 7 days | +1.56% | — |
| 14 days | -5.33% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +1.95%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥916.83M | -57.40% | +11.46% | -6.87% | 1.19 | 13.57% | +5.48% | — | — |
| 2026 interim report | 2026-08-15 | ¥644.75M | -66.55% | +7.43% | -7.39% | 0.84 | 9.06% | -1.44% | -2.74% | +3.87% |
| 2026 Q1 report | 2026-04-30 | ¥423.80M | +13.24% | +11.61% | +4.12% | 0.55 | 5.80% | +5.18% | -2.98% | -5.03% |
| 2025 annual report | 2026-03-31 | ¥2.13B | -4.41% | +6.56% | -32.70% | 2.77 | 25.57% | -5.38% | -1.84% | -10.26% |
| 2025 Q3 report | 2025-10-31 | ¥2.15B | +167.73% | +6.70% | -34.59% | 2.80 | 25.38% | +7.14% | +8.94% | +13.63% |
| 2025 interim report | 2025-08-15 | ¥1.93B | +193.08% | -5.93% | -33.15% | 2.50 | 22.30% | +6.93% | -1.25% | -11.54% |
| 2025 Q1 report | 2025-04-30 | ¥374.25M | -3.38% | -0.04% | -30.22% | 0.49 | 4.66% | +0.75% | +13.21% | +10.03% |
| 2024 annual report | 2025-03-31 | ¥2.23B | +125.94% | -21.62% | -11.14% | 2.90 | 30.51% | -3.07% | -6.60% | -5.04% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.